期刊文献+

超声介入瘤内注射无水酒精治疗不同病理分型肝癌术后复发的比较研究 被引量:8

Comparison of peit threapy effect between the recurrence node of hepatocellular carcinoma and intrahepatic cholangiocarcinoma
下载PDF
导出
摘要 目的比较普通超声引导下经皮肝穿刺注射无水酒精(PEIT)治疗不同病理分型的原发性肝癌术后复发灶的疗效,进一步探讨此治疗方法对于原发性肝癌的应用价值。方法分别选取34例肝细胞癌、25例胆管细胞癌术后复发进行PEIT治疗患者进行随访,对比分析其治疗效果。结果肝细胞癌组有效30例,有效率为88.24%(30/34),胆管细胞癌组有效者17例,有效率68%(17/25),经过卡方检验,P<0.05。结论 PEIT治疗肝细胞肝癌患者术后复发灶效果明显好于胆管细胞癌患者,胆管细胞癌患者术后复发可用其他治疗方法。 Objective To compare the efficacy of percutaneous ethol injection treatment between the recurrence node of hepatocellular carcinoma (HCC)and intrahepatic cholangiocarcinoma(ICC). Methods To choose and follow -up visit 34 hepatocellular carcinoma patients and 25 intrahepatic cholangiocarcinoma patients who were all postop and had recurrence nodes( 〈 3 cm) those had been treated by PEI. Compare and analyze the therapeutic efficacy. Result 30 cases were in effect and the efficiency rate was 88.24% of HCC(30/34), 17 cases were in effect and the efficiency rate was 68% of ICC(17/25). Through Chi - square test, there have signification of statistics (P 〈 0.05). Conclusion The therapeutic efficacy of PEIT on HCC is superior to ICC. It is correlative with the pathological characteristic of HCC and ICC.
作者 张丽 郭佳
出处 《肝胆外科杂志》 2012年第1期18-20,共3页 Journal of Hepatobiliary Surgery
关键词 肝细胞 胆管细胞 超声引导 无水酒精 疗效 hepatocellular carcinoma intrahepatic holangiocarcinoma PEIT Ultrasoundgraphy
  • 相关文献

参考文献7

二级参考文献41

  • 1王知力,董宝玮,梁萍,于晓玲,于德江,张晶.肝细胞肝癌灰阶超声强度与其组织病理相关性的研究[J].中国超声医学杂志,2004,20(8):602-605. 被引量:6
  • 2Li-WuLin Xue-YingLin Yi-MiHe Shang-DaGao En-ShengXue Xiao-DongLin Li-YunYu.Experimental and clinical assessment of percutaneous hepatic quantified ethanol injection in treatment of hepatic carcinoma[J].World Journal of Gastroenterology,2004,10(21):3112-3117. 被引量:27
  • 3祝峙,朱明华.乙型肝炎病毒X基因与肝细胞癌[J].中华病理学杂志,2006,35(7):423-426. 被引量:1
  • 4吴孟超,陈汉,姚晓平,杨甲酶,杨广顺,沈锋.原发性肝癌的外科治疗[J].中华外科杂志,1996,34(12):707-710. 被引量:121
  • 5Schurr R,Stolzel U, Schuppan D, et al. Increased incidence of hepatocellular and intrahepatic cholangiocellular carcinoma in northeast Germany. Dtsch Med Wochenschr, 2006, 131: 1649- 1655.
  • 6El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epide- miology and molecular carcinogenesis. Gastroenterology, 2007, 132:2557-2576.
  • 7Aishima S, KurodaY, NishiharaY, et al. Proposal of progression model for intrabepotic eholan giocaveinoma: clinicopathologic diferences between hilar type and peripheral type. Am J Surg Pathol, 2007,31 : 1059-1067.
  • 8Naugler WE,Sakurai T, Kim S,et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science, 2007,317 : 121-124.
  • 9Davis PL,Filly RA,Goerke J. In vitro demonstration of all echogenicemulsion: relationship of lipid particle size to echo detection. Ultrasound, 1981,9 : 9263-9266.
  • 10Isozaki T,Numata K,Kiba T,et al.Differential diagnosis of hepatic tumors by using contrast enhancement patterns at US.Radiology,2003,229:798-805.

共引文献117

同被引文献139

引证文献8

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部